Our overall Deal of the Year is Warburg Pincus’ exit of Summit Health (formerly CityMD) at a walloping $8.9bn. Our winners for best deals of 2023 are in six categories.
Deals of the Year
We name the winners for the best exits of 2023, in six categories.
Our overall Deal of the Year is Warburg Pincus’ exit of Summit Health (formerly CityMD) at a walloping $8.9 billion. The winner for the International category, BlackRock LTPC’s sale of luxury fragrance Creed, scales a lot of history, as Creed was founded in 1760 and had Queen Victoria as a customer. Other prize winners: Kaiser Permanente in Secondaries; Ares Management for Turnaround; the Mid-Market winner is Vestar Capital Partners; and Vesey Street Capital Partners wins the Small Market sector.
Our criteria for picking winners include performance metrics as well as employee retention and expansion, portfolio company growth and organic growth of companies. We also look at investment rationale, as well as methods of growth.
2023 DEALS OF THE YEAR
Deal of the Year: Warburg Pincus and Summit Health
Warburg Pincus’ massive expansion of Summit Health and subsequent exit earns it our overall deal of the year award as well as being the large-market winner.
Turnaround Deal of the Year: Ares Management and Savers Value Village
Ares made it rain during an IPO drought when it brought Savers Value Village to market.
International Deal of the Year: BlackRock Long Term Private Capital and Creed
BlackRock had a nose for the power of luxury, even during covid.
Secondaries Deal of the Year: Kaiser Permanente
Kaiser deftly closed its portfolio sale last year despite market turbulence, price fluctuations and the banking crisis
Mid-Market Deal of the Year: Vestar Capital Partners and Edward Don & Co
Vestar’s investment in a family company founded over a century ago paid off despite difficulties of the covid era
Small Market Deal of the Year: Vesey Street Capital Partners and Quality Metric
Vesey stuck to its playbook when it acquired healthcare data services firm Quality Metric